Moreover, interesting evidence reported an increased frequency of the JAK2 haplotypeGGCC_46/1 in patients with MPN characterized by splanchnic vein thrombosis (SVT), both in the presence and absence of the JAK2 V617F mutation [49,50,51,52,53]. This evidence concerns the gene JAK2 and myeloproliferative disorder.